 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Dec. 28, 2020 PRNewswire -- United Therapeutics Corporation Nasdaq: UTHR announced today an agreement to acquire a Rare Pediatric Disease Priority Review Voucher PRV, which it plans to use with a forthcoming New Drug Application... 